Camptosar
information and resources from the National Cancer Institute
Camptosar
(Other name for: irinotecan hydrochloride)
irinotecan
Accel. Approv. (clinical benefit subsequently established) Treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5-FU-based therapy.
Pharmacia & Upjohn Company Jun 14 1996
irinotecan
Follow up of treatment of metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5-FU-based therapy.
Pharmacia & Upjohn Company Oct 22 1998
irinotecan
For first line treatment n combination with 5-FU/leucovorin of metastatic carcinoma of the colon or rectum.
Pharmacia & Upjohn Company Apr 20 2000
|
|
|
|
news articles
Erbitux® Plus Camptosar® Effective in Patients with Colorectal ... Mar 29, 2006
Cancer Consultants (press release), ...to article published in the British Journal of Cancer, the treatment combination consisting of Erbitux® (cetuximab) and Camptosar® (irinotecan) provides ...
Updated Guidelines for Treatment of Ovarian Cancer Mar 27, 2006
Cancer Consultants (press release), ...of treatment options for recurrent ovarian cancer was broadened to include Arimidex® (anastrozole), Avastin® (bevacizumab), Camptosar® (ironotecan), Ifex ...
FDA gives greenlight for new treatment of head and neck cancer Mar 4, 2006
News-Medical.net, Erbitux was previously approved by the FDA to be used in combination with Camptosar (irinotecan) for the treatment of colorectal cancer that no longer responds ...
Addition of Erbitux® to Chemotherapy Promising as Initial ... Mar 7, 2006
Cancer Consultants (press release), ...recently published in the Annals of Oncology, the addition of Erbitux® (cetuximab) to the chemotherapy combination consisting of Camptosar® (irinotecan), 5 ...
First Broad Pharmacogenomics Test to Cancer Patients Mar 7, 2006
eMaxHealth.com, ...laboratory to determine through genetic screening which patients are likely to have a serious adverse reaction to irinotecan hydrochloride (Camptosar®), a key ...
South Florida Man Indicted For Selling Fake Cancer Cure Mar 15, 2006
North Country Gazette, Additionally, the indictment states that Vanmoor promoted his products on his websites under the names of FDA-approved drugs such as Pfizer’s Camptosar®. ...
NCCN Announces Important Updates to Ovarian Cancer Clinical ... Mar 6, 2006
Genetic Engineering News, ...modalities for ovarian cancer to include anastrazole (Arimidex, AstraZeneca), bevacizumab (Avastin, Genentech), irinotecan (Camptosar, Pfizer), ifosfamide (Ifex ...
Manhattan Research Reveals Top Ten Consumer-Ranked Pharmaceutical ... Mar 7, 2006
PR Newswire (press release), Advair, Allegra, Amaryl, Ambien, Androgel, Aricept, Arimidex, Avandia, Avastin, Avelox, Betaseron, Bextra, Biaxin, Boniva, Byetta, Camptosar, Celebrex, Celexa ...
FDA Approves Erbitux® For Treatment of Head and Neck Cancer Mar 2, 2006
Cancer Consultants (press release), Erbitux was previously FDA-approved to be used in combination with Camptosar® (irinotecan) for the treatment of colorectal cancer that has stopped responding ...
U Chicago researchers license pharmacogenomics test for patients ... 21 Dec 2005
EurekAlert (press release), ...have licensed a genetic test that determines which patients are likely to have a serious adverse reaction to irinotecan hydrochloride (Camptosar®), a key ...
New genetic tests boost impact of drugs 21 Dec 2005
Pittsburgh Post Gazette, Irinotecan, marketed as Camptosar by Pfizer Inc., is often used in a cocktail with other drugs in patients with advanced colon cancer. ...
Genzyme Launches Colorectal Cancer Test to Determine Appropriate ... Dec 6, 2005
Yahoo! News (press release) Assay for colorectal cancer patients in the North American market who are being considered for, or currently taking, the chemotherapy Camptosar® (irinotecan). ...
Doctor convicted of shorting patients of cancer drugs Dec 12, 2005
The Tennessean, She gave partial doses of the drugs Procrit, Taxol and Camptosar, which are used either to treat cancer or lessen chemotherapy side effects. ...
Beware Of Fake Cures & Other Medical Frauds On The Web Nov 28, 2005
PR Web (press release), They actually say their pill is Camptosar, a Pfizer drug used for treatming colon cancer, but it’s clearly not Camptosar. According ...
Doctor convicted of health-care fraud Dec 13, 2005
Gallatin News Examiner, Evidence at the trial showed that Moon mixed partial doses of the chemotherapy drugs Taxol and Camptosar and the diluted mixes were given to patients as if ...
Jury convicts Crossville doctor of overcharging for chemo drugs Dec 13, 2005
Southern Standard, Moon also mixed partial doses of other chemotherapy drugs — including Taxol and Camptosar — herself and administered those doses to patients as if they ...
Universal Adjuvant Chemotherapy Use Is Elusive for Advanced Colon ... Dec 6, 2005
MedPage Today, ...and Wellcovorin (leucovorin), but the researchers suggested that studies are needed to see if newer regimens - using such drugs as Camptosar (irinotecan) or ...
Doctor's federal fraud trial begins Nov 30, 2005
Gallatin News Examiner, Moon also took the unusual step of mixing chemotherapy drugs — including Taxol and Camptosar — herself, instead of leaving that job to a pharmacist or nurse ...
Biotech Roars Back in November Dec 1, 2005
PR Newswire (press release), UGT1A1 pharmacogenetic test, designed to detect select polymorphisms associated with adverse reactions to Pfizer's chemotherapy drug, Camptosar, the company's ...
Doctor says fraud allegations stem from irate workers Dec 1, 2005
Southern Standard, Moon also mixed chemotherapy drugs — including Taxol and Camptosar — herself instead of leaving that job to a pharmacist or nurse and did not mix full doses ...
48-Week Clinical Trial Data Provides Information Regarding ... Nov 18, 2005
Yahoo! News (press release) REYATAZ should not be taken with the following medicines: ergot medicines, Versed®, Halcion®, Orap®, Propulsid®, Camptosar®, Crixivan®, Mevacor®, Zocor ...
48-Week Clinical Trial Data Provides Information Regarding ... Nov 18, 2005
Biotech Intelligence (press release), REYATAZ should not be taken with the following medicines: ergot medicines, Versed(R), Halcion(R), Orap(R), Propulsid(R), Camptosar(R), Crixivan(R), Mevacor(R ...
|
|
